L-Arginine Reduces Neointimal Hyperplasia in Cold-Stored Arterial Allografts in a Rabbit Low-Flow-Through Model

ABSTRACT

An “off the shelf” vascular conduit for free flap surgery that remained patent until the flap is vascularized from the recipient bed would be useful to avoid autograft donor-site morbidity and reduce operation time. To date, no successful studies of microvascular prostheses in low-flow states exist. This study investigated the effects of L-arginine on neointimal hyperplasia and the overall patency of cold-stored femoral arterial allografts implanted into a low-flow arterial defect model in rabbits. A cutaneous island flap based on the inferior epigastric artery was raised, and the femoral artery was ligated distally. Immediately proximal to the inferior epigastric artery, the femoral artery was divided and a 1-cm long cold-stored femoral arterial allograft was inserted into the defect. Half of the animals received L-arginine as a subcutaneous injection. When harvested at 4 weeks, 9 out of 11 allografts of the L-arginine-treated group and 8 out of 14 grafts of the control group were patent. Intimal thickening and graft stenosis were significantly reduced in the L-arginine group. Our findings reveal the potential of a combined approach of an arterial allograft and the use of L-arginine as a short-term vein graft substitute.

L-Arginine - neointimal hyperplasia - arterial allograft - cold stored

REFERENCES

• 1 O'Brien C J, Harris J P, May J. Evaluation of a clinically useful length of 1 mm diameter PTFE as a microvascular graft.  Br J Plast Surg. 1986;  39 103-108
• 2 Ryan A D, Morrison W A, O'Brien B M. The use of long synthetic microvascular grafts in dogs with a view to clinical application.  Aust N Z J Surg. 1987;  57 667-670
• 3 Roberts A H, Wee J T, Nightingale G, MacLeod A M, O'Brien B M. Glutaraldehyde-tanned microvascular grafts.  Br J Plast Surg. 1989;  42 429-434
• 4 Chow S P, So Y C, Chan C W. Experimental microarterial grafts: freeze-dried allografts versus autografts.  Br J Plast Surg. 1983;  36 345-347
• 5 Pratt M F, Schneider J, Galey F R. Microsurgical application of freeze-dried arterial allografts.  Laryngoscope. 1986;  96 626-629
• 6 Harashina T. Arterial allografts and heterografts in microvascular surgery.  Br J Plast Surg. 1978;  31 16-18
• 7 Cruz N L, Blanco G, Cestero H J. Preserved arterial grafts in microvascular surgery.  J Microsurg. 1981;  2 250-252
• 8 Balderman S C, Montes M, Schwartz K, Hart T, Bhayana J N, Gage A A. Preparation of venous allografts: a comparison of techniques.  Ann Surg. 1984;  200 117-130
• 9 Laub G W, Muralidharan S, Clancy R et al.. Cryopreserved allograft veins as alternative coronary artery bypass conduits: early phase results.  Ann Thorac Surg. 1992;  54 826-831
• 10 Uretsky B F, Murali S, Reddy P S et al.. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.  Circulation. 1987;  76 827-834
• 11 Crowe D M, Mitchell G M, Hurley J V, Olivier T V, O'Loughlin K, Morrison W A. Cold stored femoral vessels as microvascular allografts: a preliminary study.  Microsurgery. 1994;  15 712-716
• 12 Solanes N, Rigol M, Castella M et al.. Cryopreservation alters antigenicity of allografts in a porcine model of transplant vasculopathy.  Transplant Proc. 2004;  36 3288-3294
• 13 Carrel A. Landmark article, Nov 14, 1908: Results of the transplantation of blood vessels, organs and limbs. By Alexis Carrel.  JAMA. 1983;  250 944-953
• 14 Boger R H, Bode-Boger S M, Frolich J C. Pathogenetic aspects of the L-arginine-NO metabolic pathway in arteriosclerosis and possible therapeutic aspects.  Vasa. 1996;  25 305-316
• 15 Davis M G, Dalen H, Austerheim A M, Gulbrandsen T F, Svendsen E, Hagen P O. Suppression of intimal hyperplasia in experimental vein grafts by oral L-arginine supplementation and single ex vivo immersion in deferoxamine manganese.  J Vasc Surg. 1996;  23 410-420
• 16 Davies M G, Kim J H, Dalen H, Makhoul R G, Svendsen E, Hagen P O. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.  Surgery. 1994;  116 557-568
• 17 Hamon M, Vallet B, Bauters C et al.. Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury.  Circulation. 1994;  90 1357-1362
• 18 McNamara D B, Bedi B, Aurora H et al.. L-Arginine inhibits balloon catheter-induced intimal hyperplasia.  Biochem Biophys Res Commun. 1993;  193 291-296
• 19 Pratt M F, Bank H L, Schmehl M, Horton W D. Freeze-dried microarterial replacement allografts in rabbits.  Laryngoscope. 1989;  99 1020-1026
• 20 Zheng J W, Qiu W L, Zhang Z Y, Lin G C, Zhu H G. Reconstruction of the common carotid artery with freeze dried arterial allografts in goats.  Shanghai Kou Qiang Yi Xue. 2001;  10 353-356
• 21 Crowe D M, Hurley J V, Mitchell G M, Niazi Z, Morrison W A. Long-term studies of cold-stored rabbit femoral artery and vein autografts.  Br J Plast Surg. 1998;  51 291-299
• 22 Crowe D, O'Loughlin K, Knox L et al.. Morphologic change in rabbit femoral arteries induced by storage at four degrees Celsius and by subsequent reperfusion.  J Vasc Surg. 1995;  22 769-779
• 23 Carrel A. Latent life of arteries.  J Exp Med. 1910;  12 460-486
• 24 Heys S D, Segar A, Payne S, Bruce D M, Kernohan N, Eremin O. Dietary supplementation with L-arginine: modulation of tumour-infiltrating lymphocytes in patients with colorectal cancer.  Br J Surg. 1997;  84 238-241
• 25 Khan F, Litchfield S J, McLaren M, Veale D J, Littleford R C, Belch J J. Oral L-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud's phenomenon.  Arthritis Rheum. 1997;  40 352-357
• 26 Rector T S, Bank A J, Mullen K A et al.. Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure.  Circulation. 1996;  93 2135-2141
• 27 Matera M, Castana R, Insirello L, Leonardi G. Pharmacokinetic study of the relative bioavailability and bioequivalence after oral intensive or repeated short term treatment with two polyamino acid formulations.  Int J Clin Pharmacol Res. 1993;  13 93-105
• 28 Delaney C P, McGeeney K F, Dervan P, Fitzpatrick J M. Pancreatic atrophy: a new model using serial intra-peritoneal injections of L-arginine.  Scand J Gastroenterol. 1993;  28 1086-1090